News Quantified

ADAP – adaptimmune therapeutics plc - american depositary shares (US:NASDAQ)

Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK [Yahoo! Finance]

12/2

04:07 pm

adap

Low

First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel) [Yahoo! Finance]

Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target lowered by analysts at Mizuho from $3.00 to $1.50. They now have an "outperform" rating on the stock.

Dr Crystal Mackall Confirmed to Keynote Immuno-Oncology 360º 2025

Yahoo Finance [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}